We are live on !
Find out more
TRV GP V Portfolio holdings
AUM
$498M
Turnover
0%
1-Year Est. Return
267.53%
This Fund
S&P 500
This Quarter Est. Return
+33.87%
1 Year Est. Return
+267.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$498M
AUM Growth
+$97.2M
(+24%)
Cap. Flow
-$31.4M
Cap. Flow % of AUM
Cap. Flow %
-6.3%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.4
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rapport Therapeutics
RAPP
|
+$31.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Rapport Therapeutics
RAPP
$1.16B
| $262M | 52.53% |
6,280,525
-854,708
| -12% | -$31.4M |
2024 Q4
6 quarters
|
|
2
Septerna Inc
SEPN
$2.11B
| $208M | 41.78% |
6,215,591
| – | – |
2024 Q4
6 quarters
|
|
3
Maze Therapeutics
MAZE
$1.77B
| $28.4M | 5.69% |
950,800
| – | – |
2025 Q1
5 quarters
|
|
Similar funds
GWM
TPWM
PBF
TRV GP V's Q2 2026 Portfolio in Review
As of Q2 2026, TRV GP V held 3 positions worth $498M, up 24% from $401M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRV GP V withdrew a net $31.4M in Q2 2026, reducing 1 holding. Its largest reduction was Rapport Therapeutics, cutting an estimated $31.4M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP V's biggest Q2 2026 reduction was Rapport Therapeutics, cutting an estimated $31.4M.
- TRV GP V's ten largest holdings make up 100% of its $498M portfolio in Q2 2026.
- TRV GP V opened 0 new positions and closed 0 in Q2 2026.
- TRV GP V's portfolio value rose 24% quarter-over-quarter to $498M.
Based on TRV GP V's 13F filing for Q2 2026, filed 10 Aug 2026.